BEVACIZUMAB GIVEN WITH TEMOZOLOMIDE AND RADIATION THERAPY (RT) IN NEWLY DIAGNOSED PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) REDUCES THE CHANCE OF EARLY RADIOLOGIC PROGRESSION
Publication
, Conference
Alderson, LM; Desjardins, A; Ranjan, T; Peters, KB; Friedman, HS; Vredenburgh, JJ
Published in: NEURO-ONCOLOGY
October 1, 2012
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2012
Volume
14
Start / End Page
81 / 81
Location
Washington, DC
Publisher
OXFORD UNIV PRESS INC
Conference Name
17th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Alderson, L. M., Desjardins, A., Ranjan, T., Peters, K. B., Friedman, H. S., & Vredenburgh, J. J. (2012). BEVACIZUMAB GIVEN WITH TEMOZOLOMIDE AND RADIATION THERAPY (RT) IN NEWLY DIAGNOSED PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) REDUCES THE CHANCE OF EARLY RADIOLOGIC PROGRESSION. In NEURO-ONCOLOGY (Vol. 14, pp. 81–81). Washington, DC: OXFORD UNIV PRESS INC.
Alderson, Lloyd M., Annick Desjardins, Tulika Ranjan, Katherine B. Peters, Henry S. Friedman, and James J. Vredenburgh. “BEVACIZUMAB GIVEN WITH TEMOZOLOMIDE AND RADIATION THERAPY (RT) IN NEWLY DIAGNOSED PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) REDUCES THE CHANCE OF EARLY RADIOLOGIC PROGRESSION.” In NEURO-ONCOLOGY, 14:81–81. OXFORD UNIV PRESS INC, 2012.
Alderson LM, Desjardins A, Ranjan T, Peters KB, Friedman HS, Vredenburgh JJ. BEVACIZUMAB GIVEN WITH TEMOZOLOMIDE AND RADIATION THERAPY (RT) IN NEWLY DIAGNOSED PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) REDUCES THE CHANCE OF EARLY RADIOLOGIC PROGRESSION. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2012. p. 81–81.
Alderson, Lloyd M., et al. “BEVACIZUMAB GIVEN WITH TEMOZOLOMIDE AND RADIATION THERAPY (RT) IN NEWLY DIAGNOSED PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) REDUCES THE CHANCE OF EARLY RADIOLOGIC PROGRESSION.” NEURO-ONCOLOGY, vol. 14, OXFORD UNIV PRESS INC, 2012, pp. 81–81.
Alderson LM, Desjardins A, Ranjan T, Peters KB, Friedman HS, Vredenburgh JJ. BEVACIZUMAB GIVEN WITH TEMOZOLOMIDE AND RADIATION THERAPY (RT) IN NEWLY DIAGNOSED PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) REDUCES THE CHANCE OF EARLY RADIOLOGIC PROGRESSION. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2012. p. 81–81.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2012
Volume
14
Start / End Page
81 / 81
Location
Washington, DC
Publisher
OXFORD UNIV PRESS INC
Conference Name
17th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences